Jim Cramer: Buy Home Depot, Sell JetBlue, and 3 More Stock Picks

Jim Cramer made the following calls on November 4th, 2013. What do you think about his picks?

The Home Depot, Inc. (NYSE:HD): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on September 10, 2013. The stock’s 52-week high is $81.56, and its 52-week low is $60.21. Cramer was a fan of the Home Depot, the Atlanta-based retailer of various home and outdoor improvement products. Cramer said that the Home Depot was a great way to play the housing sector because it capitalizes both on consumers buying new homes and current home owners looking to spruce up their residences, noting that the stock has risen by about 25 percent so far this year.

hd-20131105

JetBlue Airways Corporation (NASDAQ:JBLU): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Sell on April 23, 2013. The stock’s 52-week high is $7.69, and its 52-week low is $4.80. Cramer responded to a viewer query about JetBlue in the negative, saying that he prefers Delta Air Lines (NYSE:DAL). Cramer has previously noted that Delta has the best numbers of any of the major carriers, making them the go-to name in the sector right now.

jblu-20131105

BP plc (NYSE:BP): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on July 18, 2013. The stock’s 52-week high is $46.99, and its 52-week low is $39.58. Cramer said that BP was a fine option for those looking for a stock that pays high dividends. Especially with the company settling up claims related to the oil spill in the Gulf of Mexico in 2010, Cramer said that BP had room to grow.

bp-20131105

Cubist Pharmaceuticals Inc. (NASDAQ:CBST): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on March 7, 2013. The stock’s 52-week high is $68.00, and its 52-week low is $38.53. Cramer sat down with Michael Bonney, the CEO of Cubist Pharmaceuticals, to discuss the state of the company after it delivered a significant earnings and revenue miss for the previous quarter. Bonney said that the emphasis at Cubist has been on acquisitions, of which the company has made more than $1 billion worth, and not on earnings in the short term. He also noted that the company has a series of drugs in the pipeline that could add value once testing is complete within a year or two.

cbst-20131105

Lifelock Inc. (NYSE:LOCK): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Sell on October 15, 2012. The stock’s 52-week high is $16.91, and its 52-week low is $6.80. Cramer used Lifelock, the company specializing in countering identity theft, as an example of how an IPO can be a deceptive game to play. While the company, which went public some 13 months ago, initially dropped after it hit the markets, investors and managers began to realize that Lifelock had solid fundamentals and was ready to deliver superior earnings, revenues, and growth. As more people jumped on board, the stock price picked up, and the stock is now up over 100 percent from its low.

lock-20131105

Don’t Miss: Romney: Obamacare Dishonesty Hurt President’s Credibility.